Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 681956, 7 pages
http://dx.doi.org/10.1155/2011/681956
Review Article

Behçet's Disease (Adamantiades-Behçet's Disease)

1Institute of Dermato-Immunology and Allergy, Southern TOHOKU Research Institute for Neuroscience, 7-115 Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
2Pathology Division, Southern TOHOKU Research Institute for Neuroscience, 7-115 Yatsuyamada, Koriyama 963-8563, Japan
3Departments of Dermatology, School of Medicine, Fukushima Medical University, Hikarigaoka-1, Fukushima 960-1295, Japan
4Saitama Medical University, 38 Hongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan
5Department of Bacteriology, Graduate School of Medicine and Dentistry, Medical School, Okayama University, 5-1, Shikata-cho-2, Okayama 700-8558, Japan

Received 13 May 2010; Accepted 7 September 2010

Academic Editor: Fang-Ping Huang

Copyright © 2011 Fumio Kaneko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Behçet, “Über rezidivierende, aphthous durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien,” Dermatol Wochenschri, vol. 105, pp. 1152–1157, 1937. View at Google Scholar
  2. C. C. Zouboulis and W. Keitel, “A historical review of early descriptions of Adamantiades-Behçet's disease,” Journal of Investigative Dermatology, vol. 119, no. 1, pp. 201–205, 2002. View at Google Scholar · View at Scopus
  3. C. C. Zouboulis and T. May, “Pathogenesis of Adamantiades-Behçet's disease,” Medical Microbiology and Immunology, vol. 192, no. 3, pp. 149–155, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Kalayciyan and C. C. Zouboulis, “An update on Behçet's disease,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. Kaneko, T. Kaneda, O. Ohnishi et al., “Infection allergy in Behçet’s disease,” Japanese Journal of Allergology, vol. 27, no. 4, pp. 440–450, 1978. View at Google Scholar
  6. F. Kaneko, N. Oyama, and A. Nishibu, “Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms,” Yonsei Medical Journal, vol. 38, no. 6, pp. 444–454, 1997. View at Google Scholar
  7. G. Mumcu, N. Inanc, S. Z. Aydin, T. Ergun, and H. Direskeneli, “Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behçet's disease,” Clinical and Experimental Rheumatology, vol. 27, supplement 53, pp. S32–S36, 2009. View at Google Scholar
  8. K. Yokota, S. Hayashi, and S. Hayashi, “Characterization of Streptococcus sanguis isolated from patients with Behçet's disease,” Microbiology and Immunology, vol. 39, no. 9, pp. 729–732, 1995. View at Google Scholar
  9. E. Isogai, S. Ohno, K. Takashi et al., “Close association of Streptococcus sanguis uncommon serotypes with Behçet's disease,” Bifidobacterium Microflora, vol. 9, pp. 27–41, 1990. View at Google Scholar
  10. E. Isogai, S. Ohno, and S. Kotake, “Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon selotypes of Streptococcus sanguis in the oral flora,” Archives of Oral Biology, vol. 35, pp. 43–48, 1990. View at Google Scholar
  11. E. A. Graykowski, M. F. Barile, W. B. Lee, and H. R. Stanley Jr., “Recurrent aphthous stomatitis. Clinical, therapeutic, histopathologic, and hypersensitivity aspects,” Journal of the American Medical Association, vol. 196, no. 7, pp. 637–644, 1966. View at Publisher · View at Google Scholar
  12. F. Kaneko, Y. Takahashi, Y. Muramatsu, and Y. Miura, “Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behçet's disease,” British Journal of Dermatology, vol. 113, no. 3, pp. 303–312, 1985. View at Google Scholar
  13. Y. Mizushima, K. Hoshi, and K. Hoshi, “Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease—a multicenter study,” Journal of Rheumatology, vol. 16, no. 4, pp. 506–511, 1989. View at Google Scholar
  14. T. Lehner, “The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease,” International Reviews of Immunology, vol. 14, no. 1, pp. 21–32, 1997. View at Google Scholar
  15. S. Kaneko, N. Suzuki, and N. Suzuki, “Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan,” Clinical and Experimental Immunology, vol. 108, no. 2, pp. 204–212, 1997. View at Google Scholar
  16. F. Kaneko, “Behçet's disease,” in A Colour Atlas of Dermato-Immunohistology, H. Ueki and H. Yaoita, Eds., pp. 84–86, Wolf Medical Publications Ltd., London, UK, 1989. View at Google Scholar
  17. W. Lew, J. Y. Chang, J. Y. Jung, and D. Bang, “Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease,” British Journal of Dermatology, vol. 158, no. 3, pp. 505–511, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. G. Trinchieri, “Interleukin-12 and its role in the generation or TH1 cells,” Immunology Today, vol. 14, no. 7, pp. 335–338, 1993. View at Google Scholar
  19. F. Kaneko, S. Saito, A. Togashi, N. Oyama, and K. Nakamura, “Prick test with self-saliva as an auxiliary diagnostic measure in Behçet's disease,” Japanese Journal of Dermatology, vol. 120, pp. 1901–1905, 2010. View at Google Scholar
  20. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Current concept Behçet's disease,” New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at PubMed
  21. H. Serhat Inaloz, C. Evereklioglu, B. Unal, N. Kirtak, A. Eralp, and S. S. Inaloz, “The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 1, pp. 56–61, 2004. View at Publisher · View at Google Scholar
  22. S. Ohno, M. Onguchi, and S. Hirose, “Close association of HLA-Bw51 with Behçet's disease,” Archives of Ophthalmology, vol. 100, no. 9, pp. 1455–1458, 1982. View at Google Scholar
  23. N. Mizuki, H. Inoko, and S. Ohno, “Molecular genetics (HLA) of Behçet's disease,” in Behçet's Disease—A Guide to Its Clinical Understanding, S. Lee, D. Bang, E.-S. Lee, and S. Sohn, Eds., pp. 87–100, Springer, London, UK, 2001. View at Google Scholar
  24. M. Takeno, A. Kariyone, N. Yamashita, M. Takiguchi, Y. Mizushima, H. Kaneoka, and T. Sakane, “Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice,” Arthritis and Rheumatism, vol. 38, no. 3, pp. 426–433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yasuoka, Y. Okazaki, Y. Kawakami, M. Hirakata, H. Inoko, Y. Ikeda, and M. Kuwana, “Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3658–3662, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H. Yanagihori, N. Oyama, K. Nakamura, N. Mizuki, K. Oguma, and F. Kaneko, “Role of IL-12B promoter polymorphism in Adamantiades-Behçet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1534–1540, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. K. Oguma, R. Shin, and K. Yokota, “Studies on immunological responses by bacterial antigens in Behçet's disease,” Reports of the Research Group for Behçet's disease, Japanese Ministry of Health, Labour and Welfare, 2008, 2006-2007, pp.31–33. View at Google Scholar
  28. G. Mumcu, N. Inanc, and N. Inanc, “Oral health is impaired in Behçet's disease and is associated with disease activity,” Rheumatology, vol. 43, pp. 1028–1033, 2004. View at Google Scholar
  29. E. Isogai, H. Isogai, and H. Isogai, “Antibody cross reactivity from sera of patients with Behçet's disease with synthetic peptides that have homologies with proteins from Streptococcus sanguis,” Journal of Applied Research, vol. 2, no. 3, pp. 1–10, 2002. View at Google Scholar
  30. E. Isogai, H. Isogai, S. Kotake, S. Ohno, K. Kimura, and K. Oguma, “Role of Streptococcus sanguis and traumatic factors in Behçet's disease,” Journal of Applied Research, vol. 3, no. 1, pp. 64–75, 2003. View at Google Scholar
  31. M. Tojo, H. Yanagihori, and H. Yanagihori, “Bes-1 DNA Fragment Encoding Streptococcal Antigen in Skin Lesions From Patients With Behçet's Disease,” Journal of Applied Research, vol. 3, no. 3, pp. 232–238, 2003. View at Google Scholar
  32. F. Kaneko, N. Oyama, H. Yanagihori, E. Isogai, K. Yokota, and K. Oguma, “The role of streptococcal hypersensitivity in the pathogenesis of Behçet's disease,” European Journal of Dermatology, vol. 18, no. 5, pp. 489–498, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. S. Jindal, A. K. Dudani, B. Singh, C. B. Harley, and R. S. Gupta, “Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen,” Molecular and Cellular Biology, vol. 9, no. 5, pp. 2279–2283, 1989. View at Google Scholar
  34. J. R. Lamb and D. B. Young, “T cell recognition of stress proteins. A link between infectious and autoimmune disease,” Molecular Biology and Medicine, vol. 7, no. 4, pp. 311–321, 1990. View at Google Scholar
  35. T. Lehner, E. Lavery, R. Smith, R. Van Der Zee, Y. Mizushima, and T. Shinnick, “Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome,” Infection and Immunity, vol. 59, no. 4, pp. 1434–1441, 1991. View at Google Scholar
  36. K. Pervin, A. Childerstone, and A. Childerstone, “T cell epitope expression of mycobacterial and homologous human 65- kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease,” Journal of Immunology, vol. 151, no. 4, pp. 2273–2282, 1993. View at Google Scholar
  37. F. Poccia, P. Piselli, S. Vendetti, S. Bach, A. Amendola, R. Placido, and V. Colizzi, “Heat-shock protein expression on the membrane of T cells undergoing apoptosis,” Immunology, vol. 88, no. 1, pp. 6–12, 1996. View at Google Scholar
  38. T. Ergun, U. Ince, and U. Ince, “HSP 60 expression in mucocutaneous lesions of Behçet's disease,” Journal of the American Academy of Dermatology, vol. 45, no. 6, pp. 904–909, 2001. View at Publisher · View at Google Scholar · View at PubMed
  39. H. Direskeneli, E. Ekşioǧlu-Demiralp, Ş. Yavuz, T. Ergun, T. Shinnick, T. Lehner, and T. Akoǧlu, “T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease,” Journal of Rheumatology, vol. 27, no. 3, pp. 708–713, 2000. View at Google Scholar
  40. Y. Imamura, M. S. Kurokawa, and M. S. Kurokawa, “Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 371–378, 2005. View at Publisher · View at Google Scholar · View at PubMed
  41. W. Hu, A. Hasan, and A. Hasan, “Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351,” European Journal of Immunology, vol. 28, no. 8, pp. 2444–2455, 1998. View at Publisher · View at Google Scholar
  42. P. A. Phipps, M. R. Stanford, and M. R. Stanford, “Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit,” European Journal of Immunology, vol. 33, no. 1, pp. 224–232, 2003. View at Publisher · View at Google Scholar · View at PubMed
  43. M. Stanford, T. Whittall, and T. Whittall, “Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behçet's disease,” Clinical and Experimental Immunology, vol. 137, no. 1, pp. 201–208, 2004. View at Publisher · View at Google Scholar · View at PubMed
  44. I. Bank, M. Duvdevani, and A. Livneh, “Expansion of γδ T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers,” Journal of Laboratory and Clinical Medicine, vol. 141, no. 1, pp. 33–40, 2003. View at Publisher · View at Google Scholar · View at PubMed
  45. K. A. Zarember and P. J. Godowski, “Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines,” Journal of Immunology, vol. 168, no. 2, pp. 554–561, 2002. View at Google Scholar · View at Scopus
  46. V. Hornung, S. Rothenfusser, and S. Rothenfusser, “Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides,” Journal of Immunology, vol. 168, no. 9, pp. 554–561, 2002. View at Google Scholar
  47. S. Yavuz, Y. Elbir, A. Tulunay, E. Eksioglu-Demiralp, and H. Direskeneli, “Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis,” Rheumatology International, vol. 28, no. 5, pp. 401–406, 2008. View at Publisher · View at Google Scholar · View at PubMed
  48. S. Ohno, S. Nakamura, and S. Nakamura, “Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis,” Journal of Rheumatology, vol. 31, no. 7, pp. 1362–1368, 2004. View at Google Scholar
  49. M. Calguneri, I. Ertenli, S. Kiraz et al., “Effect of prophylacticbenzathine penicilline on mucocutaneous symptoms of Behçet's disease,” Rheumatology International, vol. 192, pp. 125–128, 1996. View at Google Scholar
  50. G. Mumcu, N. Inanc, S. Yavuz, and H. Direskeneli, “The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease,” Clinical and Experimental Rheumatology, vol. 25, no. 4, pp. S27–S33, 2007. View at Google Scholar